Promotion of hematogenous metastatic potentials in human KB carcinoma cells with overexpression of cyclooxygenase-2

Oncology Reports

Volumn 24, Issue 3, 2010, Pages 733-739

  Segawa, Emi ^a   Kishimoto, Hiromitsu ^a   Takaoka, Kazuki ^a   Noguchi, Kazuma ^a   Hashitani, Susumu ^a   Sakurai, Kazunari ^a   Urade, Masahiro ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

CD44; COX 2; Metastasis; Oral cancer; siRNA

Indexed keywords

ALPHA CATENIN; BETA CATENIN; CYCLOOXYGENASE 2; HERMES ANTIGEN; SMALL INTERFERING RNA; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE METASTASIS; CANCER CELL CULTURE; CARCINOGENICITY; COLONY FORMATION; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG METASTASIS; LYMPH NODE; MOUSE; MOUTH CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ALPHA CATENIN; ANIMALS; ANTIGENS, CD44; BETA CATENIN; BONE NEOPLASMS; CADHERINS; CARCINOMA; CELL PROLIFERATION; CYCLOOXYGENASE 2; FEMALE; HUMANS; KB CELLS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MICE; MICE, INBRED BALB C; MICE, NUDE; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION; TUMOR BURDEN; UP-REGULATION;

EID: 77956318992     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000915     Document Type: Article

References (38)

1. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA and Jothy S: Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 55: 2556-2559, 1995.
2. Ristimaki A, Honkanen N, Jankala H, Sipponen P and Harkonen M : Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57: 1276-1280, 1997.
3. Parrett ML, Harris R, Joarder FS, Ross MS, Clausen KP and Robertson FM: Cyclooxygenase-2 gene expression in human breast cancer. Int J Oncol 10: 503-507, 1997. (Pubitemid 27122013)
4. Hida T, Yatabe Y, Achiwa H, et al: Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 58: 3761-3764, 1998.
5. Mestre JR, Subbaramaiah K, Sacks PG, Schantz SP, Tanabe T, Inoue H and Dannenberg AJ: Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells. Cancer Res 57: 2890-2895, 1997. (Pubitemid 27315035)
6. Chan G, Boyle JO, Yang EK, et al: Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 59: 991-994, 1999.
7. Nishimura G, Yanoma S, Mizuno H, Kawakami K and Tsukuda M: A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells. Jpn J Cancer Res 90: 1152-1162, 1999.
8. Sakurai K, Urade M, Noguchi K, et al: Increased expression of cyclooxygenase-2 in human salivary gland tumors. Pathol Int 51: 762-769, 2001.
9. Tsujii M, Kawano S and DuBois RN: Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94: 3336-3340, 1997. (Pubitemid 27157312)
10. Tomozawa S, Tsuno NH, Sunami E, et al: Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer. Br J Cancer 83: 324-328, 2000.
11. Takaoka K, Kishimoto H, Segawa E, et al: Elevated cell migration, invasion and tumorigenicity in human KB carcinoma cells transfected with COX-2 cDNA. Int J Oncol 29: 1095-1101, 2006.
12. Ovejera AA, Houchens DP and Baker AD: Chemotherapy of human tumor xenografts in genetically athymic mice. Ann Clin Lab Sci 8: 50-56, 1978. (Pubitemid 8272354)
13. Kishimoto H, Wang Z, Bhat-Nakshatri P, Chang D, Clarke R and Nakshatri H: The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/ paracrine activity of SDF-1α/CXCL12. Carcinogenesis 26: 1706-1715, 2005.
14. Boyle DL, Rosengren S, Bugbee W, Kavanaugh A and Firestein GS: Quantitative biomarker analysis of synovial gene expression by real-time PCR. Arthritis Res Ther 5: 352-360, 2003.
15. Hashitani S, Urade M, Nishimura N, Maeda T, Takaoka K, Noguchi K and Sakurai K: Apoptosis induction enhancement of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head neck carcinoma cell lines. Int J Oncol 23: 665-672, 2003.
16. Sakurai K, Urade M, Noguchi K, Hashitani S, Takaoka K, Segawa E and Kishimoto H: Prognostic significance of cyclooxygenase-2 and DNA topoisomerase IIα expression in oral carcinoma. Head Neck 29: 1002-1009, 2007.
17. Gallo O, Franchi A, Magnelli L, et al: Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia 3: 53-61, 2001.
18. Lin DT, Subbaramaiah K, Shah JP, Dannenberg AJ and Boyle JO: Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer. Head Neck 24: 792-799, 2002.
19. Uchida D, Begum NM, Tomizuka Y, Bando T, Almofti A, Yoshida H and Sato M: Acquisition of lymph node, but not distant metastatic potentials, by the overexpression of CXCR4 in human oral squamous cell carcinoma. Lab Invest 84: 1538-1546, 2004. (Pubitemid 39600561)
20. Roche-Nagle G, Connolly EM, Eng M, Bouchier-Hayes DJ and Harmey JH: Antimetastatic activity of a cyclooxygenase-2 inhibitor. Br J Cancer 91: 359-365, 2004.
21. Yamauchi T, Watanabe M, Hasegawa H, et al: The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer. Anticancer Res 23: 245-249, 2003.
22. Yao M, Lam EC, Kelly CR, Zhou W and Wolfe MM: Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer. Br J Cancer 90: 712-719, 2004.
23. Sharp JA, Waltham M, Williams ED, Henderson MA and Thompson EW: Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice. Clin Exp Metastasis 21: 19-29, 2004. (Pubitemid 38365654)
24. Zhang JH, Tang J, Wang J, Ma W, Zheng W, Yoneda T and Chen J: Overexpression of bone sialoprotein enhances bone metastasis of human breast cancer cells in a mouse model. Int J Oncol 23: 1043-1048, 2003.
25. Muller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001.
26. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS and McCauley LK: Use of the stromal cell-derived factor-1/ CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 62: 1832-1837, 2002.
27. Schrader AJ, Lechner O, Templin M, et al: CXCR4/CXCL12 expression and signalling in kidney cancer. Br J Cancer 86: 1250-1256, 2002.
28. Zushi Y, Noguchi K, Hashitani S, et al: Relations among expression of CXCR4, histological patterns and metastatic potential in adenoid cystic carcinoma of the head and neck. Int J Oncol 33: 1133-1139, 2008.
29. Chiang AC and Massagué J: Molecular basis of metastasis. N Engl J Med 359: 2814-2823, 2008.
30. Dohadwala M, Luo J, Zhu L, et al: Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. J Biochem 276: 20809-20812, 2001.
31. Tian B, Takasu T and Henke C: Functional role of cyclin A on induction of fibroblast apoptosis due to ligation of CD44 matrix receptor by anti-CD44 antibody. Exp Cell Res 257: 135-144, 2000. (Pubitemid 30324651)
32. Ponta H, Sherman L and Herrlich PA: CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4: 33-45, 2003.
33. Harada N, Mizoi T, Kinouchi M, et al: Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells. Int J Cancer 91: 67-75, 2001.
34. Reeder JA, Gotley DC, Walsh MD, Fawcett J and Antalis TM: Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Cancer Res 58: 3719-3726, 1998. (Pubitemid 28376574)
35. Yu Q and Stamenkovic I: Localization of matrix metallo-proteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 13: 35-48, 1999.
36. Takahashi K, Eto H and Tanabe KK: Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells. Int J Cancer 80: 387-395, 1999. (Pubitemid 29019625)
37. Zhang Y, Thant AA, Machida K, et al: Hyaluronan-CD44s signaling regulates matrix metalloproteinase-2 secretion in a human lung carcinoma cell line QG90. Cancer Res 62: 3962-3965, 2002.
38. Kinugasa Y, Hatori M, Ito H, Kurihara Y, Ito D and Nagumo M: Inhibition of cyclooxygenase-2 suppresses invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 and CD44. Clin Exp Metastasis 21: 737-745, 2004.